Literature DB >> 6741032

Fluctuating levels of serum IgA in individuals with selective IgA deficiency.

C Laschinger, D Gauthier, J P Valet, D H Naylor.   

Abstract

Monitoring of donors with selective IgA deficiency, i.e., with less than 0.5 mg IgA/l, led to the observation that serum IgA levels wer not constant. Small but significant fluctuations in IgA levels were noted (coefficient of variance: 143%) which were greater than the variability inherent in the testing methodology (coefficient of variance: 10%). These fluctuations created difficulties in terms of defining IgA-deficient blood products and had implications with respect to the mechanisms involved in IgA deficiency. With respect to supplying IgA-deficient blood products, in our experience a cutoff level of 0.5 mg/l should be the maximum permissible IgA concentration in order to ensure that no adverse reactions occur in individuals with class-specific anti-IgA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6741032     DOI: 10.1111/j.1423-0410.1984.tb01562.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  4 in total

1.  Long-term follow-up of anti-IgA antibodies in healthy IgA-deficient adults.

Authors:  S Koskinen; H Tölö; M Hirvonen; J Koistinen
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

2.  Long-term persistence of selective IgA deficiency in healthy adults.

Authors:  S Koskinen; H Tölö; M Hirvonen; J Koistinen
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

3.  Pokeweed mitogen and Staphylococcus aureus Cowan I induced immunoglobulin A synthesis by lymphocytes of IgA deficient blood donors.

Authors:  K Oen; M L Schroeder; D Krzekotowska
Journal:  Clin Exp Immunol       Date:  1985-11       Impact factor: 4.330

4.  Immunological investigations in individuals with selective IgA deficiency.

Authors:  T A Out; P J van Munster; P A De Graeff; T H Thé; J M Vossen; B J Zegers
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.